Folketrygdfondet’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.57M | Buy |
172,796
+2,411
| +1% | +$49.8K | 0.08% | 10 |
|
2025
Q1 | $3.34M | Hold |
170,385
| – | – | 0.07% | 10 |
|
2024
Q4 | $3.56M | Hold |
170,385
| – | – | 0.08% | 11 |
|
2024
Q3 | $4.15M | Hold |
170,385
| – | – | 0.08% | 12 |
|
2024
Q2 | $4.28M | Hold |
170,385
| – | – | 0.08% | 13 |
|
2024
Q1 | $5.1M | Hold |
170,385
| – | – | 0.11% | 11 |
|
2023
Q4 | $5.43M | Hold |
170,385
| – | – | 0.11% | 10 |
|
2023
Q3 | $6.01M | Hold |
170,385
| – | – | 0.12% | 10 |
|
2023
Q2 | $6.48M | Hold |
170,385
| – | – | 0.15% | 10 |
|
2023
Q1 | $6.43M | Buy |
170,385
+10,008
| +6% | +$378K | 0.15% | 10 |
|
2022
Q4 | $6.8M | Buy |
160,377
+3,311
| +2% | +$140K | 0.14% | 10 |
|
2022
Q3 | $5.05M | Hold |
157,066
| – | – | 0.11% | 10 |
|
2022
Q2 | $5.1M | Buy |
157,066
+152,100
| +3,063% | +$4.94M | 0.11% | 10 |
|
2022
Q1 | $137K | Sell |
4,966
-132,685
| -96% | -$3.67M | 0.08% | 9 |
|
2021
Q4 | $5.45M | Hold |
137,651
| – | – | 0.13% | 10 |
|
2021
Q3 | $6.02M | Sell |
137,651
-3,656
| -3% | -$160K | 0.15% | 10 |
|
2021
Q2 | $5.77M | Buy |
141,307
+23,317
| +20% | +$952K | 0.17% | 9 |
|
2021
Q1 | $3.87M | Sell |
117,990
-69,578
| -37% | -$2.28M | 0.13% | 9 |
|
2020
Q4 | $7.63M | Hold |
187,568
| – | – | 0.28% | 8 |
|
2020
Q3 | $6.87M | Hold |
187,568
| – | – | 0.29% | 8 |
|
2020
Q2 | $63.6M | Hold |
187,568
| – | – | 2.57% | 5 |
|
2020
Q1 | $39.7M | Buy |
187,568
+12,000
| +7% | +$2.54M | 1.92% | 6 |
|
2019
Q4 | $39.2M | Hold |
175,568
| – | – | 1.28% | 9 |
|
2019
Q3 | $3.56M | Buy |
+175,568
| New | +$3.56M | 0.12% | 10 |
|